HealthBeacon plc
HBCNF
Other OTC0.50
USD
+0.48
- -
ISIN
IE00014QAJZ5
Return %
Stock
S&P500
1Y
-66.67
26.53
3Y
-84.62
76.60
5Y
-84.62
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Kieran Daly
- Full Time Employees
- 70
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Unit 20, Naas Road Business Park Dublin Ireland D12 WD85
- IPO Date
- Aug 31, 2022
- Website
- healthbeacon.com
- Similar Companies
- Business
- HealthBeacon plc (Ticker: HBCNF), a digital therapeutics company and subsidiary of Hamilton Beach Health, develops and provides smart connected devices and platforms for medication adherence and injection care management targeting patients with chronic conditions managing injectable therapies at home. The company offers its flagship Injection Care Management System (ICMS), including the Smart Sharps Bin for reminders, adherence tracking, safe sharps disposal with reuse and recycling features, and AI-driven data analytics; HB Wave for prescription refill notifications and visual pill adherence monitoring; HB Smart Scale for weight tracking integration; and the Global Patient Safety Platform, a software solution enabling clinicians to prescribe medications and access behavior-based insights. It sells and leases these medical adherence devices, systems, and risk management platforms on a subscription basis to pharmaceutical companies such as Teva and Novartis, healthcare providers including the NHS, and patients across Europe, the United States, Canada, the United Kingdom, North America, Australia, and Ireland, where operations span up to 15 countries with FDA approval. Founded in 2013 and headquartered in Dublin, Ireland, at Unit 18 Naas Road Business Park, HealthBeacon was acquired by Hamilton Beach Brands Holding Company's Hamilton Beach Health subsidiary in February 2024, finalizing the purchase price allocation by December 2024; this followed a 2021 exclusive multiyear U.S. distribution partnership and supports expanded rollouts under the Hamilton Beach Health brand, remote therapeutic monitoring growth, and further home medical collaborations.
HealthBeacon eyes funding, updates market on cash position
HealthBeacon confident in ‘significant growth prospects', if its appropriately funded